Felix Carl Wiegandt

Breath-Triggered Drug Release for Preterm Neonates


voorkant	achterkant

ISBN:

978-3-8440-8870-0

Reeks:

Schriftenreihe Mikrotechnik
Uitgever: Prof. Dr. rer.nat. Andreas Dietzel
Braunschweig

Trefwoorden:

aerosol; abdominal movement; breath-triggered drug release; optical detection; preterm infant; preterm neonate; real-time measurement; test bed; time-of-flight camera

Soort publicatie:

Dissertatie

Taal:

Engels

Pagina's:

102 pagina's

Gewicht:

145 g

Formaat:

21 x 14,8 cm

Bindung:

Softcover

Prijs:

39,80 € / 49,80 SFr

Verschijningsdatum:

December 2022

Kopen:

Download:

Beschikbare online documenten voor deze titel:

U heeft Adobe Reader, nodig, om deze bestanden te kunnen bekijken. Hier vindt u ondersteuning en informatie, bij het downloaden van PDF-bestanden.

Let u er a.u.b. op dat de online-bestanden niet drukbaar zijn.


	Document		Document
	Soort bestand		PDF
	Kosten		29,85 EUR
	Acties		Tonen en kopen van het bestand - 3,6 MB (3810257 Byte)
	Acties		Kopen en downloaden van het bestand - 3,6 MB (3810257 Byte)


	Document		Inhoudsopgave
	Soort bestand		PDF
	Kosten		gratis
	Acties		Het bestand tonen - 628 kB (643126 Byte)
	Acties		downloaden van het bestand - 628 kB (643126 Byte)

Gebruikersinstellingen voor geregistreerde online-bezoekers

Hier kunt u uw adresgegevens aanpassen en uw documenten inzien.

Gebruiker:	niet aangemeld
Acties:	aanmelden/registreren Paswoord vergeten?

Aanbevelen:

Wilt u dit boek aanbevelen?

Recensie-exemplaar

Bestelling van een recensie-exemplaar.

Verlinking

Wilt u een link hebben van uw publicatie met onze online catalogus? Klik hier.

Samenvatting

Inhalation therapy is a form of treatment for respiratory diseases. However, a major disadvantage of inhalation therapy using continuous drug delivery to the patient is the waste of drug during exhalation. The development of a breath-triggered drug delivery system can greatly reduce this waste. In preterm and term neonates, this is further complicated by their challenging respiratory parameters such as high respiratory rates, low tidal volumes and short inhalation times. Given these challenges, there is currently no technology that enables breath-triggered drug release directly at the patient interface of preterm and term neonates. To close this gap, it is not only necessary to develop devices that enable efficient drug release at high frequencies but also test beds that can be used to determine the efficiency of drug release. Moreover, the respiratory phases must be detected to release the aerosol in synchrony with the respiration.

Therefore, an overall system consisting of aerosol output determination, breath-triggered aerosol release and breath detection is presented in this thesis as follows:

1. A test bed, consisting of gravimetric and optical particle detection, allows the determination of the aerosol output in real time as well as the determination of the particles’ water content.
2. A breath-triggered aerosol delivery system, consisting of a novel patient interface with an integrated micronized aerosol valve, allows direct and rapid breath-triggered delivery of aerosol as a targeted bolus at different times of inhalation.
3. A respiratory detection system, consisting of a time-of-flight camera for recording the abdominal movement of preterm neonates, enables the determination of respiratory parameters as well as respiratory patterns.

The overall system has potential to form the cornerstone for more efficient inhalation therapy for (preterm) neonates.

Profiel (auteursprofiel)

As of 2014, Felix has been working at Fraunhofer Institute for Toxicology and Experimental Medicine in Hannover specializing in a breath-triggered drug delivery system for (pre)term infants. He developed a system that allows the release of an aerosol in a breath-triggered manner to (pre)term infants, achieving great improvements which far surpass the standard used in the clinic in terms of efficiency. With several publications and international patents under his belt, Felix knows the importance of driving innovation.